Foundation for Biomedical Research and Innovation at KobeNEWS
- Monthly
-
2023.11.30 Pressrelease
Activation of neurogenesis in the hippocampus is a novel therapeutic target for Alzheimer's disease: our research team’s findings published in Neuroprotection on November 21, 2023 -
2023.07.27 Pressrelease
SETBP1 is dispensable for normal and malignant hematopoiesis: our research team’s findings published ‘Leukemia’ on July 18, 2023 -
2023.01.16 Pressrelease
Professor Akio Ohta’s research group defined immunosuppressive anti-PD-1 antibodies and published in Science Immunology on January 13, 2023 -
2022.07.01
FBRI’ research on Acute Myeloid Leukemia publish in Blood -
2022.05.13 Pressrelease
The research team of the Department of Hematology-Oncology, Institute of Biomedical Research and Innovation and the University of Tokyo elucidates a novel regulatory mechanisms by which MDS cells inhibit normal hematopoiesis, published in Cell Reports on May 10, 2022
-
2022.02.03
Dr. Taguchi Akihiko’s research was published in Frontiers in Aging Neuroscience
(Published: February 3, 2022) -
2021.12.28
Thank you to our donors
See a complete list of donors who have supported the FBRI in 2021. -
2021.04.13
Dr. Daichi Inoue’s research was published in Nature Genetics (Published: April 12, 2021) -
2021.03.11
Dr. Taguchi Akihiko’s research was published in Stem Sells (Published: March11, 2021) -
2021.02.05
TreeFrog Therapeutics in partnership with QC-Stem consortium (Foundation for Biomedical Research and Innovation at Kobe and others) has received 2020 Galien Medstartup Award in “Best Collaboration in the Pharmaceutical or Biotechnology Industry” category
(Published: October 27, 2020)